Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
107,313
-
Share change
-
+17,864
-
Total reported value
-
$292,493
-
Price per share
-
$2.61
-
Number of holders
-
12
-
Value change
-
+$46,588
-
Number of buys
-
6
-
Number of sells
-
2
Institutional Holders of Xenetic Biosciences, Inc. - COM (XBIO) as of Q1 2025
As of 31 Mar 2025,
Xenetic Biosciences, Inc. - COM (XBIO) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,313 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, LGT Group Foundation, GEODE CAPITAL MANAGEMENT, LLC, Sachetta, LLC, JTC Employer Solutions Trustee Ltd, UBS Group AG, BANK OF AMERICA CORP /DE/, and SBI Securities Co., Ltd..
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.